Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127021671 | 12702167 | 1 | I | 201605 | 20160825 | 20160831 | 20160831 | PER | US-PFIZER INC-2016404513 | PFIZER | 59.00 | YR | M | Y | 76.00000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127021671 | 12702167 | 1 | PS | VFEND | VORICONAZOLE | 1 | Oral | 200 MG, 2X/DAY | Y | 21266 | 200 | MG | FILM-COATED TABLET | BID | |||||
127021671 | 12702167 | 2 | C | TACROLIMUS. | TACROLIMUS | 1 | Oral | 2.5 MG, DAILY (0.5 MG CAPSULE, 3 CAPSULES IN THE MORNING AND 2 CAPSULES IN EVENING) | 0 | 2.5 | MG | CAPSULE | |||||||
127021671 | 12702167 | 3 | C | TACROLIMUS. | TACROLIMUS | 1 | Oral | 4 MG, 2X/DAY (1MG, 4 IN THE MORNING AND 4 AT NIGHT) | 0 | 4 | MG | CAPSULE | BID | ||||||
127021671 | 12702167 | 4 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 500 MG, 2X/DAY (ONCE IN THE MORNING AND ONCE AT NIGHT) | 0 | 500 | MG | TABLET | BID | ||||||
127021671 | 12702167 | 5 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 500 MG, 4X/DAY | 0 | 500 | MG | TABLET | QID | ||||||
127021671 | 12702167 | 6 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 10 MG, 2X/DAY (5MG, 2 TABLETS TWICE A DAY) | 0 | 10 | MG | TABLET | BID | ||||||
127021671 | 12702167 | 7 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 10 MG, 1X/DAY (2 TABLETS ONCE A DAY) | 0 | 10 | MG | TABLET | QD | ||||||
127021671 | 12702167 | 8 | C | VALCYTE | VALGANCICLOVIR HYDROCHLORIDE | 1 | Oral | 450 MG, 1X/DAY | 0 | 450 | MG | TABLET | QD | ||||||
127021671 | 12702167 | 9 | C | VALCYTE | VALGANCICLOVIR HYDROCHLORIDE | 1 | Oral | 2 TABLETS ONCE A DAY | 0 | 2 | DF | TABLET | QD | ||||||
127021671 | 12702167 | 10 | C | DAPSONE. | DAPSONE | 1 | Oral | UNK UNK, 1X/DAY (100MG TABLETS, ONCE A DAY) | 0 | TABLET | QD | ||||||||
127021671 | 12702167 | 11 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, 1X/DAY | 0 | 81 | MG | TABLET | QD | ||||||
127021671 | 12702167 | 12 | C | PRAVACHOL | PRAVASTATIN SODIUM | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | ||||||
127021671 | 12702167 | 13 | C | FLUDROCORTISONE ACETATE. | FLUDROCORTISONE ACETATE | 1 | Oral | 0.1 MG, ALTERNATE DAY | 0 | .1 | MG | TABLET | QOD | ||||||
127021671 | 12702167 | 14 | C | FLUDROCORTISONE ACETATE. | FLUDROCORTISONE ACETATE | 1 | Oral | 0.1 MG, DAILY | 0 | .1 | MG | TABLET | |||||||
127021671 | 12702167 | 15 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | ||||||
127021671 | 12702167 | 16 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | TABLET | |||||||||||
127021671 | 12702167 | 17 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 2000 IU, 2X/DAY (1000IU, TABLET, 2 IN THE MORNING AND 2 AT NIGHT) | 0 | 2000 | IU | TABLET | BID | ||||||
127021671 | 12702167 | 18 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 1200 MG, DAILY (400MG, TABLET, 3 A DAY) | 0 | 1200 | MG | TABLET | |||||||
127021671 | 12702167 | 19 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 800 MG, DAILY (2 A DAY) | 0 | 800 | MG | TABLET | |||||||
127021671 | 12702167 | 20 | C | CALCIUM | CALCIUM | 1 | 1000 MG, 2X/DAY | 0 | 1000 | MG | TABLET | BID | |||||||
127021671 | 12702167 | 21 | C | CALCIUM | CALCIUM | 1 | Oral | 1000 MG, 2X/DAY (ONE TABLET TWICE A DAY) | 0 | 1000 | MG | TABLET | BID | ||||||
127021671 | 12702167 | 22 | C | DRONABINOL. | DRONABINOL | 1 | Oral | 2.5 MG, AS NEEDED | 0 | 2.5 | MG | CAPSULE | |||||||
127021671 | 12702167 | 23 | C | DRONABINOL. | DRONABINOL | 1 | 0 | CAPSULE | |||||||||||
127021671 | 12702167 | 24 | C | OXYCODONE | OXYCODONE | 1 | Oral | 5 MG, AS NEEDED | 0 | 5 | MG | TABLET | |||||||
127021671 | 12702167 | 25 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 200 MG, 1X/DAY (100MG, TWO TABLETS, ONCE A DAY) | 0 | 200 | MG | TABLET | QD | ||||||
127021671 | 12702167 | 26 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
127021671 | 12702167 | 27 | C | WELLBUTRIN SR | BUPROPION HYDROCHLORIDE | 1 | Oral | 150 MG, 1X/DAY | 0 | 150 | MG | TABLET | QD | ||||||
127021671 | 12702167 | 28 | C | WELLBUTRIN SR | BUPROPION HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
127021671 | 12702167 | 29 | C | WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 1 | 150 MG, 1X/DAY | 0 | 150 | MG | QD | ||||||||
127021671 | 12702167 | 30 | C | WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 1 | 0 | ||||||||||||
127021671 | 12702167 | 31 | C | MUCINEX | GUAIFENESIN | 1 | Oral | 600 MG, AS NEEDED | 0 | 600 | MG | TABLET | |||||||
127021671 | 12702167 | 32 | C | MUCINEX | GUAIFENESIN | 1 | 0 | TABLET | |||||||||||
127021671 | 12702167 | 33 | C | DOXYCLINE MONO | 2 | Oral | 100 MG, 2X/DAY (ONCE IN THE MORNING AND ONCE AT NIGHT) | 0 | 100 | MG | CAPSULE | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127021671 | 12702167 | 1 | Fungal infection |
127021671 | 12702167 | 2 | Transplant rejection |
127021671 | 12702167 | 4 | Transplant rejection |
127021671 | 12702167 | 6 | Transplant rejection |
127021671 | 12702167 | 8 | Prophylaxis |
127021671 | 12702167 | 10 | Bacterial infection |
127021671 | 12702167 | 11 | Thrombosis prophylaxis |
127021671 | 12702167 | 12 | Prophylaxis |
127021671 | 12702167 | 13 | Blood potassium increased |
127021671 | 12702167 | 15 | Gastric ulcer |
127021671 | 12702167 | 16 | Dyspepsia |
127021671 | 12702167 | 17 | Routine health maintenance |
127021671 | 12702167 | 18 | Routine health maintenance |
127021671 | 12702167 | 20 | Routine health maintenance |
127021671 | 12702167 | 22 | Nausea |
127021671 | 12702167 | 23 | Appetite disorder |
127021671 | 12702167 | 24 | Pain |
127021671 | 12702167 | 25 | Affective disorder |
127021671 | 12702167 | 26 | Depression |
127021671 | 12702167 | 27 | Affective disorder |
127021671 | 12702167 | 28 | Depression |
127021671 | 12702167 | 29 | Affective disorder |
127021671 | 12702167 | 30 | Depression |
127021671 | 12702167 | 31 | Cough |
127021671 | 12702167 | 32 | Productive cough |
127021671 | 12702167 | 33 | Bacterial infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127021671 | 12702167 | HO |
127021671 | 12702167 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127021671 | 12702167 | Generalised anxiety disorder | |
127021671 | 12702167 | Hallucination | |
127021671 | 12702167 | Paranoia | |
127021671 | 12702167 | Pneumonia | |
127021671 | 12702167 | Rash | |
127021671 | 12702167 | Visual field defect |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127021671 | 12702167 | 1 | 20160728 | 0 | ||
127021671 | 12702167 | 2 | 201605 | 20160728 | 0 | |
127021671 | 12702167 | 3 | 20160728 | 0 | ||
127021671 | 12702167 | 4 | 201605 | 20160728 | 0 | |
127021671 | 12702167 | 5 | 20160728 | 0 | ||
127021671 | 12702167 | 6 | 201605 | 0 | ||
127021671 | 12702167 | 8 | 201605 | 0 | ||
127021671 | 12702167 | 10 | 201605 | 0 | ||
127021671 | 12702167 | 12 | 201605 | 0 | ||
127021671 | 12702167 | 17 | 201605 | 0 | ||
127021671 | 12702167 | 22 | 20160510 | 20160607 | 0 | |
127021671 | 12702167 | 24 | 201605 | 0 | ||
127021671 | 12702167 | 31 | 201606 | 0 | ||
127021671 | 12702167 | 33 | 20160718 | 20160731 | 0 |